Pennsylvania SB1206 amends the definition of "virtual manufacturer" and modifies license application requirements for wholesale prescription drug.
Pennsylvania SB1206 amends the Wholesale Prescription Drug Distributors License Act by updating the definition of "virtual manufacturer" to include those who hold FDA approval or have submitted an application for approval within 12 months. It also specifies that virtual manufacturers must not take physical possession of any drug or device in the Commonwealth. The bill modifies license application requirements, stating that the Department may not require FDA approval of a drug or device as a condition of licensure.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.